1. Introduction
The incidence of metastatic spine disease continues to increase despite improved cancer treatment options [
1,
2], and the spinal column remains the most common site of osseous metastasis [
1,
3]. With roughly 33–70% [
1,
3,
4] of solid cancer patients developing spinal involvement, nearly 20% of these patients will develop symptomatic spinal cord compression [
1,
3,
4,
5]. Surgical intervention for these symptomatic lesions has shown to be effective in improving neurological outcomes, pain, and even quality of life [
1,
5,
6].
Patients with metastatic spine disease, with or without cord compression, can present either in an organized fashion to a clinic or in a more urgent manner to the emergency department (ED). When an acute neurologic deficit occurs, ED evaluation is necessary. However, neurologically intact patients with mechanical pain can also present to the ED in a less urgent manner. In a retrospective analysis of over 300 patients undergoing metastatic spine surgery, Zanaty et al. 2022 [
7] showed the majority presented emergently through the ED, with that same cohort having a longer length of stay (LOS) and lower average survival compared to those presenting to the clinic [
7]. Moreover, some current research suggests that involvement of a tumor board in patients with spinal metastasis can decrease the rate of ED presentation, the need for emergent surgery, and improve outcomes [
2]. Thus, it is imperative to assess risk factors that predispose patients to present emergently through the ED and also compare overall outcomes after surgical intervention.
Given the different presentation settings of patients undergoing surgery for metastatic spine disease, gaining a better understanding of how and why these patients present may improve care. Therefore, in a cohort of patients undergoing metastatic spine surgery, we sought to (1) determine the rate of ED presentation, (2) identify preoperative and perioperative risk factors associated with ED presentation, and (3) evaluate whether ED vs. clinic presentation impacts long-term outcomes.
2. Methods
2.1. Study Design
A single-institution, multi-surgeon, retrospective case-control study was undertaken for patients undergoing metastatic spinal tumor surgery between February 2010 and January 2021. Institutional review board (IRB) approval was obtained for this study (IRB#211900).
2.2. Patient Population
Registry data were selected for patients who underwent surgery for spinal metastasis between 2010 and 2021. Inclusion criteria were adult patients (18 years old or above) with metastatic extradural spinal tumors who underwent spinal surgery for tumor resection or stabilization. Exclusion criteria consisted of pediatric patients (less than 18 years old), intradural tumors, and primary tumors. The date of the last follow-up was extended to the date of death or the date of the last clinical follow-up.
2.3. Exposure Variable
The primary exposure variable was presentation setting, dichotomized as either the clinic or the ED. The clinic setting was a priori, defined as a surgeon’s office, directly referred by an oncologist, radiation oncologist, or primary care physician. The ED was defined as any urgent care or emergency room setting, or inter-hospital transfer. Additional exposure variables were divided into preoperative and perioperative variables. Preoperative variables included demographics of age, sex, and body mass index (BMI). Other factors included associated comorbidities, smoking status, insurance type, and primary organ disease. Perioperative variables included pain status (mechanical, biologic, neurologic), motor/sensory deficits, tumor size and location, preoperative Karnofsky Performance Scale (KPS), Bilsky Score, and preoperative chemotherapy or radiotherapy. Other variables included type of surgery, total instrumented levels, total decompressed levels, estimated blood loss, intraoperative monitoring changes, operative time, length of stay (LOS), discharge disposition, and complications.
2.4. Outcome Variable
The primary outcomes of interest included postoperative outcomes of functional status, measured with the Karnofsky Performance Scale (KPS) and McCormick Scale (MMS), local recurrence (LR), and overall survival (OS). Secondary outcomes included complications and readmissions.
2.5. Surgical Treatment
All patients underwent surgery in accordance with the strategy of separation surgery, consisting of spinal cord decompression and long-segment posterior stabilization and fusion [
8,
9,
10,
11]. Patients were most often taken for a posterior approach, potentially involving a transpedicular approach or costotransversectomy to achieve adequate spinal cord decompression. The goal of adequate spinal cord decompression was to achieve a separation between the tumor and the spinal cord, in addition to reconstituting the thecal sac, to achieve a safe distance from the tumor to the spinal cord for adequate radiation dosing. Ultrasound was used often to confirm adequate spinal cord decompression. Anterior column reconstruction was sometimes performed depending on the extent of kyphosis, the presence of a lytic lesion, and surgeon preference.
2.6. Statistical Analysis
Descriptive statistics were reported to compare preoperative and postoperative variables. The mean and SD were reported for continuous variables and frequency for categorical variables. Normal distribution and variance for continuous variables were assessed with the Shapiro–Wilk test and F test, respectively. Parametric data with equal variance were analyzed with a two-tailed t-test, while nonparametric data were compared with the Wilcoxon signed rank or Mann–Whitney test. The χ2 or Fisher exact test was used for nominal data. A Kaplan–Meier plot, as well as univariable/multivariable logistic/cox/linear regressions, were performed, controlling for age, comorbidities, preop KPS, the primary organ of origin, and the presence of other organ metastases. An α value < 0.05 was considered statistically significant. All analyses were performed using R, version 4.1.3 (The R Foundation, Vienna, Austria).
4. Discussion
The current study assessed patients undergoing surgical intervention for metastatic spine disease and determined risk factors and differences between patients who presented to the ED vs. clinic. Patients presenting to the ED were older, had more comorbidities, and more often had public insurance. ED patients also had a lower preoperative KPS score and higher Bilsky score, though the rate of preoperative neurologic deficits was similar. Operatively, ED patients underwent larger decompressions and, more often, costotransversectomies with a longer LOS. Despite similar rates of postoperative chemotherapy and RT and controlling for several confounding variables, ED patients had a significantly decreased OS. These results shed light on the less healthy and overall higher-risk patient population that ultimately presents to the ED with lower overall survival compared to clinic patients.
Patients presenting through the ED had more comorbidities, higher rates of public insurance, higher Bilsky scores, and higher rates of biologic pain. The current literature has clearly established insurance type as a mediator of prehospital management and overall outcomes in oncology patients [
12,
13]. In a study focusing on the impact of public insurance on tumor burden, Price et al. [
12] found that those with public insurance had higher rates of metastatic spinal cord compression and paralysis, were less likely to receive surgery, and had longer hospital stays. While our study did not find differences in the degree of compression via the Bilsky score, we found those presenting to the ED were more likely to have public insurance, which points toward socioeconomic factors that may predispose these patients to less optimal resources and pre-surgical follow support, thus leading to worse outcomes. Biologic pain is often associated with increased inflammation, and knowing that tumor invasion often leads to inflammatory cascades within surrounding tissue [
14,
15], we suspect that this finding suggests a larger tumor burden with a more rapidly progressed disease for those presenting to the ED. This complex interplay between lower socioeconomic status, more advanced disease, and presenting to the ED highlights a potential area of research. A broader discussion of addressing disparities in care may serve as fruitful to improve the care of metastatic spine patients.
Regarding perioperative differences between ED and clinic patients, we found a more extensive decompression required in the ED patient population. The requirement of a more robust surgical intervention may be due in part to a higher tumor burden creating destruction to surrounding soft tissue and bone through local invasion, thus necessitating a more extensive decompression of neural elements. The most commonly reported complication of wound breakdown was in line with what our data suggests [
10].
Despite no significant difference in postoperative KPS and MMS, our data suggests a longer hospital stay for surgical patients presenting through the ED. This discrepancy is further highlighted by the fact that the ED patient cohort was less likely to be discharged and, thus, more likely to be sent to a facility. Given there were no differences in neurological deficits or other surgical complications, this suggests less home support for patients presenting to the ED, which makes sense given the unexpected need for postoperative care at home. Of note, KPS was improved postoperatively for both cohorts, which validates the reasons for surgery. However, it declined at the time of the last follow-up, which presents the natural progression of patients with metastatic spinal tumors.
Lastly, and perhaps our most notable findings, patients undergoing spinal metastatic surgery who presented to the ED had lower odds of survival compared to those presenting for elective surgery through a clinic. Despite controlling for several confounding variables, including postoperative chemotherapy and radiation, ED patients had lower odds of survival. Reasons for this are multifactorial but may relate to the lower socioeconomic status of these patients or a more rapidly progressing disease. Thus, it is imperative to understand the perioperative risk factors that lead to ED presentations to improve outcomes and survival among this patient population. Once patients’ symptoms reach the point of requiring ED admission, the battle may have already been lost. Further research should focus on ways to detect metastatic spine disease during surveillance of patients with cancer and educating patients on what to look for in those without cancer but with strong family histories of such.
There are several limitations to this study, which may limit the generalizability of the results. First, we did not identify clinic patients who were sent directly to the ED, which is a population of patients that would be interesting to separately identify and analyze and could have confounded results. Second, there are other factors that could influence patient outcomes, including time to surgery, type of instrumentation, length of surgery, drain management, and type of radiation. Furthermore, a sub-analysis of the primary organ of origin could not be performed due to the small sample size. Third, there was limited data regarding patient presentation to other hospitals postoperatively, which could alter our findings on wound complications, readmission, and reoperation rates. Fourth, the overall prognosis postoperatively depends widely on targeted treatment modalities specific to the genetic profiles of the patient’s primary tumors. The molecular basis of the patient’s primary tumor was not included in our study and thus limits our postoperative analysis. We aim to include molecular data in future studies, as this is an important and growing area of spinal oncology. Fifth, the study was performed at a single academic institution within the United States, and thus, it is possible these findings may not reflect the general population. This ultimately limits our generalizability to differing healthcare systems abroad, such as publicly managed national health systems. A larger multicenter and multinational study should be designed to uncover additional factors associated with ED vs. clinic presentation for metastatic spine surgery.